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during reperfusion. To understand the relationship between ischemic mitochondrial damage and
mitochondrial-driven cell death, the isolated perfused heart underwent global stop-ﬂow ischemia
with and without mitochondrial protection by reversible blockade of electron transport. Ischemic
damage to electron transport depleted bcl-2 content and favored mitochondrial permeability
transition (MPT). Reversible blockade of electron transport preserved bcl-2 content and attenuated
calcium-stimulated mitochondrial swelling. Thus, the damaged electron transport chain leads to
bcl-2 depletion and MPT opening. Chemical inhibition of bcl-2 with HA14-1 also dramatically
increased mitochondrial swelling, augmented by exogenous H2O2 stress, indicating that bcl-2
depleted mitochondria are poised to undergo MPT during the enhanced oxidative stress of
reperfusion.
 2011 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Mitochondrial dysfunction contributes to myocardial injury
during ischemia-reperfusion [1]. Ischemia results in damage to
the electron transport chain (ETC) and decreased rates of oxidative
phosphorylation [2,3]. Reperfusion after ischemia does not result
in additional damage to electron transport [4,5], although, in con-
trast to mitochondria, substantial cardiomyocyte injury occurs
during reperfusion [6–8]. Mitochondrial-dependent cardiac injury
involves the increased production of reactive oxygen species
(ROS) [9–12], the depletion of anti-apoptotic proteins from mito-
chondria [13,14], and increased susceptibility to opening of the
mitochondrial permeability transition pore (MPT) [14–17]. Protec-
tion of mitochondria against ischemic damage to the ETC by the
reversible blockade of electron transport during ischemia [18,19]
or other pharmacological treatments [20–22] decreases myocar-
dial injury assessed following reperfusion [4,23,24], thus establish-
ing a link between damage to electron transport during ischemia
and cardiomyocyte death during reperfusion.on behalf of the Federation of Euro
ion, Medical Service 111(J),
rd, Richmond, VA 23249, USA.
efsky@va.gov (E.J. Lesnefsky).Although decreased activity of the electron transport chain
could contribute to myocardial injury during reperfusion via de-
creased respiration and energy production, reperfused myocar-
dium can be protected by intervention only during reperfusion.
Brief, reversible blockade of electron transport during reperfusion
[23,25] or the use of postconditioning consisting of brief periods
of intermittent ischemia [26], protect reperfused myocardium de-
spite the persistence of ischemia-induced ETC damage during
reperfusion [26,27]. Thus, mitochondrial-dependent processes
other than decreased oxidative phosphorylation must account for
the mitochondrial-dependent injury observed during reperfusion.
The ETC-dependent processes that generate cardiac injury during
reperfusion remain unclear.
The mitochondrial permeability transition pore (MPT) is a
non-selective pore spanning the inner and outer mitochondrial
membranes. MPT opening is a key contributor to cardiac injury
during ischemia-reperfusion [28]. MPT opening is favored at the
onset of reperfusion due to increased oxidative stress, rapid
normalization of intracellular pH, and mitochondrial calcium load-
ing [15,16,28,29]. Ischemic damage to the electron transport chain
increases ROS generation during re-oxygenation [10,30], whereas
prevention of ischemic damage decreases ROS generation during
reperfusion [4,31]. Thus, ischemic damage to the ETC may
contribute to cardiac injury during reperfusion via ROS generation
that facilitates MPT opening. The permeability of the outerpean Biochemical Societies.
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bcl-2 family proteins [13,32]. A decreased content of anti-apoptotic
proteins (bcl-2, bcl-xl) and/or the increased content of pro-apopto-
tic proteins (bax and bak) will lead to permeation of the outer
membrane and cytochrome c loss [13,32]. Ischemia-reperfusion
decreases myocardial bcl-2 content in the isolated heart [33] and
bcl-2 inhibition with the small molecule HA14-1 abrogates cardio-
protection [34]. However, the potential electron transport chain
dependence of bcl-2 depletion is unknown.
Blockade of the proximal electron transport chain protects
mitochondria during ischemia [19], providing an experimental
model to identify and study the mechanisms of ETC-dependent
cardiac injury. Mitochondria were studied at the end of ischemia,
in order to exclude potential contributions of in situ reperfusion
to mitochondrial damage. The current study found that bcl-2
depletion frommitochondria during ischemia is indeed ETC depen-
dent. Decreased bcl-2 content, perhaps in concert with increased
ROS generation from the damaged ETC, increases the probability
of mitochondrial permeability transition. Thus, an increased pre-
disposition to permeability transition and activation of pro-
grammed cell death are complimentary, reinforcing mechanisms
that translate ETC damage from ischemia into cardiomyocyte
death during reperfusion.2. Materials and methods
2.1. Isolated rabbit heart model of ischemia and reperfusion
The Animal Care and Use Committees of the Louis Stokes VA
Medical Center and Case Western Reserve University approved
the protocol. The isolated rabbit heart perfusion protocol was
performed as described previously [3,5] (Supplementary data).
Untreated ischemic hearts were ﬁrst perfused with Krebs–Hense-
leit buffer for 15 min followed by 30 min stop-ﬂow ischemia. In
amobarbital treated ischemic hearts, amobarbital (2.5 mM) [18]
in oxygenated Krebs–Henseleit buffer was infused for 1 min imme-
diately before ischemia. Time control hearts were perfused for
45 min without ischemia [2].
There were no differences in hemodynamic parameters be-
tween time control, untreated ischemia, and amobarbital treated
ischemia groups at the end of the 15 min equilibration period be-
fore the infusion of amobarbital (Supplementary Table 1). Devel-
oped pressure was maintained during 45 min perfusion in time
control hearts (88 ± 6 at 15 min equilibration and 85 ± 1 mmHg
at end of 45 min perfusion). Ischemia led to myocardial contrac-
ture and markedly increased diastolic pressure compared to the
pre-ischemic value. Amobarbital treatment signiﬁcantly attenu-
ated the increase in diastolic pressure compared to the untreated
heart as previously described (Supplementary Table 1).
2.2. Isolation and analysis of two populations of cardiac mitochondria
At the end of ischemia, hearts were removed from the perfusion
column and placed into Chappell–Perry buffer [(in mM) 100KCl,
50MOPS, 1EGTA, 5MgSO47H2O, and 1ATP; pH 7.4] at 4 C. Cardiac
mitochondria were isolated according to Palmer et al. [35], with
minor modiﬁcations as previously described [3] (Supplementary
data). Oxygen consumption in mitochondria was measured using
a Clark-type oxygen electrode at 30 C (Stratkelvin, Scotland, UK)
in a solution containing 80 mM KCl, 50 mM MOPS, 1 mM EGTA,
5 mM KH2PO4, and 1 mg/ml BSA, at pH 7.4. Glutamate (complex I
substrate), and TMPD-ascorbate plus rotenone (complex IV
substrate) were used as electron donors [3]. Cytochrome contents
were measured in mitochondria solubilized in 2% deoxycholate in
10 mM sodium phosphate buffer using the difference of sodiumdithionite reduced and air oxidized spectra [3,36]. H2O2 production
from intact mitochondria was measured using the oxidation of
the ﬂuorogenic indicator Amplex Red in the presence of horseradish
peroxidase (HRP) [37]. Glutamate (10 mM) and succinate (10 mM)
were used as substrates.
2.3. Western blot analysis
SSM were solubilized and boiled for 5 min in buffer including
4% (w/v) SDS, 1 mM 2-mercaptoethanol, 10 mM Tris/HCl (pH 6.8)
and 10% (w/v) glycerol. Equal amounts of protein (100 lg) were
loaded onto 14% SDS–PAGE, run and transferred to PVDF mem-
brane. The membranes were ﬁrst blotted by 5% non-fat milk for
one hour. Then membranes were blotted with primary antibodies
for one hour or overnight. Antibodies to bcl-2 (catalog number:
2876) bax (2722), and subunit 4 of cytochrome oxidase (4844)
were purchased from Cell Signaling Technology (Danvers, MA).
The blots were incubated with peroxidase conjugated anti-rabbit
antibody (1:5000) for 1 h prior to ECL detection. The intensities
of blotting were quantiﬁed by densitometer (GS800 densitometer,
Golden Valley, MN).
2.4. Mitochondrial swelling analysis
Opening of the mitochondrial pore was determined by Ca2+ in-
duced swelling of isolated mitochondria measured as a reduction
in A520. Isolated SSM or IFM (0.25 mg/ml) were resuspended in
swelling buffer (120 mM KCl, 5 mM KH2PO4, 50 mM MOPS, pH
7.4) with succinate (10 mM) as substrate. Absorbance was deter-
mined at 520 nm and MPT induced by 200 lM CaCl2. Cyclosporine
A (1 lM) inhibited swelling by approximately 90% (Fig. 4), conﬁrm-
ing the decrease in absorbance was due to MPT. Results were ex-
pressed as D change of absorbance /mg protein [38]. To test the
effect of HA14-1 on MPT opening, isolated control rabbit SSM were
incubated with HA14-1 (20 lM) [39] in the absence and presence
of H2O2 (100 lM) [40] for 5 min at 30 C and mitochondrial swell-
ing was determined.
2.5. Statistical analysis
Data are expressed as the mean ± standard error of the mean.
Not every sample was available for each assay and led to different
animal numbers in different assays. Differences among groups
were compared by one-way analysis of variance with post hoc
comparisons performed using the Student–Newman–Keuls test of
multiple comparisons. A difference of p < 0.05 was considered sig-
niﬁcant (SigmaStat for Windows Version 1.0, Jandel Corporation).3. Results
3.1. Blockade of electron transport protects oxidative phosphorylation
in SSM during ischemia
Thirty minutes of ischemia decreased the maximal rate of
ADP-stimulated respiration in SSM and IFM with glutamate as
substrate, as previously described in this model [2,3]. In contrast,
glutamate oxidation in SSM isolated from hearts with blockade
of electron transport during ischemia due to amobarbital treat-
ment was similar to rates observed in SSM from time control
hearts (Table 1). Ischemia also decreased dinitrophenol-uncoupled
respiration in SSM and IFM compared to time control, and this
defect was prevented by amobarbital treatment (Table 1). Oxida-
tive phosphorylation through cytochrome oxidase also decreased
in SSM following ischemia. Amobarbital treatment preserved
respiration through cytochrome oxidase, indicating that blockade
Table 1
Blockade of electron transport with amobarbital preserves respiration following
ischemia.
Time control (n = 7) Ischemia (n = 9) AMO (n = 10)
Subsarcolemmal mitochondria (SSM)
Glutamate-ADP 175 ± 10 104 ± 8* 167 ± 8**
Glutamate-DNP 155 ± 10 102 ± 10* 157 ± 11**
TMPD-asc-ADP 504 ± 17 315 ± 21* 540 ± 31**
Interﬁbillilar mitochondria (IFM)
Glutamate-ADP 252 ± 10 186 ± 18* 260 ± 12**
Glutamate-DNP 252 ± 20 189 ± 27* 273 ± 24**
TMPD-asc-ADP 858 ± 53 714 ± 22 810 ± 49
Data are expressed as Mean ± SEM.
* P < 0.05 vs. time control.
** P < 0.05 vs. ischemia. AMO, amobarbital + ischemia ADP, 2 mM; DNP (dinitro-
phenol, 0.3 mM).
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tron transport chain against ischemic damage (Table 1). Ischemia
did not damage the distal electron transport chain in IFM (Table
1), consistent with previous ﬁndings [2,3].
3.2. Blockade of electron transport during ischemia prevents bcl-2
depletion
Ischemia decreased the content of bcl-2 in SSM compared to
time control, whereas blockade of electron transport during ische-
mia preserved bcl-2 content (Fig. 1). In contrast, ischemia did not
substantially alter the bax content in SSM compared to time con-
trol or amobarbital treated SSM (Fig. 1). Equal protein loading
was conﬁrmed by the detection of subunit IV of cytochrome oxi-
dase (Fig. 1). These results indicate that the ETC lies upstream of
and contributes to bcl-2 depletion during ischemia. Bcl-2 could
not be detected in IFM, likely secondary to the protease treatment
used during isolation.
3.3. Blockade of electron transport during ischemia decreases net H2O2
production from SSM
Ischemic damage to the ETC increased the net production of
H2O2 in SSM oxidizing glutamate as a complex I substrate. The in-Fig. 1. Blockade of electron transport during ischemia preserves bcl-2 content in
SSM. Ischemia markedly decreases the bcl-2 content in SSM isolated from rabbit
heart compared to time control, whereas amobarbital prevents bcl-2 depletion
during ischemia. Ischemia did not alter bax content compared to time control or
amobarbital treated hearts. The upper panel consists of representative immuno-
blots, and the lower panel is the quantitation using densitometery (Mean ± S.E.M.;
⁄P < 0.05 vs. time control; ⁄⁄P < 0.05 vs. untreated-ischemia).creased H2O2 generation from SSM is also observed following
ischemia with succinate as a complex II substrate in the presence
of rotenone. Amobarbital treatment during ischemia decreased
ROS generation from the ETC (Fig. 2). Thus, ischemic damage to
electron transport increased the net ROS production. Ischemia also
tended to increase H2O2 generation from IFM isolated after ische-
mia when glutamate is the substrate, but the results did not reach
statistical difference (Fig. 2).
3.4. Blockade of electron transport during ischemia preserves
cytochrome c content
The cytochrome c content in SSM decreased after 30 minutes of
ischemia, whereas amobarbital treatment preserved cytochrome c
content (Supplementary Table 2). Other cytochrome contents (c1,
b, aa3) were unaffected. Ischemia did not alter cytochrome con-
tents in IFM (Supplementary Table 2).
3.5. Blockade of electron transport during ischemia attenuates the
opening of MPT
Ischemia signiﬁcantly increased the calcium-induced swelling
of SSM compared to time control. The SSM protected by amobarbi-
tal treatment during ischemia exhibited substantially decreased
swelling compared to the SSM isolated from untreated ischemic
hearts (Fig. 3). Ischemia also led to calcium-induced swelling in
IFM, but the rate and extent of swelling was less than in SSM
(Fig. 3).
3.6. Inhibition of bcl-2 markedly induced MPT opening during
oxidative stress
Mitochondrial swelling was used as an in vitro index of the
susceptibility to opening of the permeability transition pore [38].
In the original tracing portion of Fig. 4 (top), calcium (200 lM)
stimulation led to mitochondrial swelling indicated by a decreaseFig. 2. The net release of H2O2 from isolated mitochondria in the presence and
absence of ischemia. Compared to SSM from time control hearts, ischemic damage
to the electron transport chain increases net H2O2 production from SSM using
glutamate as complex I substrate and succinate + rotenone as a complex II
substrate. In contrast, protection of SSM by blockade of electron transport during
ischemia by amobarbital decreases the H2O2 generation compared to the untreated
ischemia (upper panel). Ischemia also tends to increase H2O2 generation in IFM
compared to time control (lower panel) (Mean ± S.E.M.; ⁄P < 0.05 vs. time control;
⁄⁄P < 0.05 vs. untreated-ischemia).
Fig. 3. Blockade of electron transport during ischemia prevents calcium-induced
swelling in SSM following ischemia. Ischemia leads to a signiﬁcant increase in
calcium-stimulated swelling in SSM. Blockade of electron transport protects SSM
and limits the swelling compared to untreated mitochondria following ischemia.
Ischemia also induces calcium-stimulated swelling in IFM, albeit to a lesser degree
(Mean ± S.E.M.; ⁄P < 0.05 vs. time control; ⁄⁄P < 0.05 vs. untreated ischemic group).
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ment increased swelling in control SSM (Fig. 4 top and bottom). In
addition, H2O2 stimulation in the presence of HA14-1 dramatically
increased swelling compared to H2O2 or HA14-1 treatment alone.
Cyclosporine A prevented H2O2 or HA14-1 stimulated swelling,
indicating that swelling occurred via MPT opening (Fig. 4 top and
bottom).
4. Discussion
Blockade of electron transport during ischemia decreases ROS
production and the probability of MPT opening. Ischemia decreases
bcl-2 content whereas protection of the electron transport chain by
amobarbital inhibition preserves the bcl-2 content, providing
strong support that the electron transport chain contributes to
the previously observed [41,42] bcl-2 depletion during ischemia.
The decreased bcl-2 content facilitates MPT opening in the
presence of oxidative stress. The current results indicate that theFig. 4. Inhibition of bcl-2 with the small molecule inhibitor HA14-1 increases mitochon
there is an additive effect when H2O2 is applied in the presence of HA14-1. The upper pan
The lower panel shows the summed results of mitochondrial swelling induced by
inhibitor + H2O2 + cyclosporine A (CSA) (Mean ± S.E.M.; ⁄P < 0.05 vs. control SSM; ⁄⁄P <
results in CSA-sensitive mitochondrial swelling, indicting that these treatments increaseischemia-induced decrease in bcl-2 content in combination with
increased ROS generation from the damaged electron transport
chain will trigger MPT opening and increase cardiac injury during
early reperfusion.
Mitochondria are the key mediators of cardiomyocyte survival
and death during ischemia-reperfusion, mediated in large part
via MPT opening [28,32]. The exact components of the MPT are
not clear, although cyclophilin D in the mitochondrial matrix reg-
ulates MPT opening [43]. Although MPT may open during cardiac
ischemia [44–46], MPT opening mostly occurs during reperfusion
[14,15,17,28,32,47–49]. Electron microscopy discloses that mito-
chondria remain intact in the isolated rabbit heart at the end of
ischemia [3], supporting that MPT does not open during ischemia
in situ [17]. The burst of ROS generation and rapid normalization
of intracellular pH during early reperfusion are key factors that in-
duce MPT [28,29]. Ischemic damage to electron transport increases
ROS generation in isolated mitochondria [10]. In contrast, revers-
ible blockade of electron transport only during ischemia decreases
ROS generation from mitochondria isolated following reperfusion
[4]. Moreover, reversible blockade of electron transport decreases
in situ ROS generation during reperfusion [31]. Thus, the ETC is
the source of ROS generation, and ischemia-damagedmitochondria
release ROS during reperfusion [11]. In the present study, we found
that the ischemia-damaged electron transport chain increased ROS
generation accompanied by mitochondrial swelling. In isolated
mitochondria, oxidative stress induced by exogenous H2O2 in-
creased mitochondrial swelling. These results suggest that the
ischemia-damaged ETC increases MPT opening by inducing ROS
generation.
Although SSM were isolated at the end of ischemia, the swelling
assay was conducted under the conditions of physiological pH,
oxygen content, substrate, and high concentration of calcium. This
condition is similar to the intracellular environment encountered
by mitochondria during early reperfusion. In the same milieu,
SSM isolated from ischemic hearts yet without ischemic damage
as a result of amobarbital treatment did not exhibit signiﬁcantdrial swelling in SSM isolated from non-ischemic control rabbit hearts. In addition,
el shows representative tracings (to preserve clarity, only select tracings are shown).
the bcl-2 inhibitor, H2O2 treatment, bcl-2 inhibitor + H2O2 treatment, and bcl-2
0.05 vs. other groups; #P < 0.05 vs HA14-1 + H2O2). HA14-1 and H2O2 stimulation
MPT opening.
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quired for MPT opening. Our results support that ischemic damage
to the ETC is a mechanism of MPT opening during reperfusion.
Bcl-2 is an anti-apoptotic protein located on the outer mito-
chondrial membrane and endoplasmic reticulum [13,50]. Overex-
pression of bcl-2 decreases ischemia-reperfusion injury in
isolated hearts [42], whereas functional inhibition of bcl-2 with
HA14-1, a small molecule that prevents bcl-2 inhibition of pro-
apoptotic proteins [40], blocked cardioprotection [34]. Inhibition
of bcl-2 with HA14-1 stimulates mitochondrial swelling [34], indi-
cating that manipulation of bcl-2 function impacts MPT opening
[13,14]. In the current study, ischemic damage to the ETC de-
creased bcl-2 content and favored MPT opening, whereas blockade
of electron transport during ischemia prevented the loss of bcl-2 in
association with the decreased mitochondrial swelling. In isolated
mitochondria, inhibition of bcl-2 increased calcium-stimulated
mitochondrial swelling, and swelling was further enhanced in
the presence of oxidative stress. At the onset of reperfusion, re-
oxygenation leads to ROS generation from the ischemia-damaged
ETC [4,31,51]. This oxidative stress occurs in the setting of de-
creased mitochondrial bcl-2 content and favors MPT opening,
eventually leading to the ischemia-reperfusion injury [28]. Thus,
preservation of bcl-2 content via reversible blockade of electron
transport contributes to reduced myocardial injury during ische-
mia-reperfusion by inhibition of MPT opening.
Damage to the ETC occurs mainly during ischemia [3,27,52] and
persists during reperfusion [5,26]. The unexpected ﬁnding that
interventions that protect myocardium during reperfusion, includ-
ing postconditioning [26,47] and brief inhibition of electron
transport [23,25] are effective without the recovery of oxidative
phosphorylation [26] point to ETC dependent processes other than
respiration as key effectors of mitochondrial-driven cardiac injury.
In the present study, enhanced net production of oxidants, shift of
the mitochondrial outer membrane proteome to a pro-apoptotic
ensemble via depletion of bcl-2, and enhanced susceptibility to
mitochondrial permeability transition are mechanisms that trans-
duce the electron transport chain damage caused by ischemia into
cardiomyocyte death during reperfusion.
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